Please login to the form below

Sanofi Genzyme

This page shows the latest Sanofi Genzyme news and features for those working in and with pharma, biotech and healthcare.

European Commission approves potential new treatment for Pompe disease

The European Commission (EC) has issued a marketing authorisation for Sanofi Genzyme’s therapy Nexviadyme (avalglucosidase alfa) for the long-term treatment of both late-onset and infantile-onset Pompe disease. ... In November 2021, Sanofi announced

Latest news

2022 PM Society Awards

Other client Gold winners were Allergan Aesthetics, an AbbVie Company, Campaign Against Living Miserably (CALM), Fresenius Kabi, Greenwich BioSciences, Mölnlycke, Novo Nordisk, Roche/Chugai, Sanofi Genzyme and ViiV Healthcare.
FDA accepts Priority Review for Dupixent in children with moderate-to-severe atopic dermatitis

If approved, Dupixent – developed by Regeneron Pharmaceuticals and Sanofi Genzyme – would be used as a supplementary treatment for managing moderate-to-severe atopic dermatitis and is aimed at children whose condition
Sanofi unveils new corporate brand and logo

Sanofi Pasteur and Sanofi Genzyme will unite under the new brand image. ... Sanofi Pasteur and Sanofi Genzyme are focused on providing specialised care and vaccine research, respectively and will come together following the new branding as one united
Sanofi and Regeneron’s Dupixent receives second positive phase 3 trial results

The latest news from Sanofi Genzyme and Regeneron Pharmaceuticals shared positive results from the second phase 3 for Dupixent (dupilumab), a medicine the companies developed to target chronic inflammatory skin diseases. ... Dupixent is a jointly
Results for the inaugural QiC Dermatology Awards 2021 in association with Dermatology in practice announced!

The awards took place at the Reading office of the QiC Dermatology Awards sponsor, Sanofi Genzyme. ... The awards took place at the Reading office of the QiC Dermatology Awards sponsor, Sanofi Genzyme, and were presented by Dr Hilary Jones.

More from news
Approximately 18 fully matching, plus 80 partially matching documents found.

Latest Intelligence

Sourcing R&D innovation: why pharma companies need to evolve their business models

One example is Genzyme (now Sanofi Genzyme), a pioneer in the rare disease space with a focus on R&D efforts targeting enzyme replacement therapies for lysosomal storage disorders and leading ... including Shire/Takeda, Actelion/J&J, Sanofi Genzyme,
Case study: See Below

Client:Sanofi Genzyme and Regeneron. Agency:Havas Lynx Group. Campaign:See Below. Timescale:N/A. Atopic dermatitis affects approximately 1-3% of adults worldwide. ... Topical corticosteroids are commonly used to treat atopic dermatitis. Sanofi Genzyme
Case study: OptiMiSe for MS nurses

Client:Sanofi Genzyme. Agency:Vivid – A Lucid Group Company. Campaign:OptiMiSe for MS nurses: a tailored, added-value support service for clinical behaviour change towards optimised services. ... It has also resulted in Sanofi Genzyme SOM-led support
Innovation and digital health comms recognised at Communiqué Awards

Innovation in Healthcare Communications. One high profile winning campaign was Havas Lynx Group’s ‘See Below’ on behalf of Sanofi Genzyme and Regeneron.
Case study: The World vs MS

Client:Sanofi Genzyme. Agency:H4B Manchester. Campaign:The World vs MS. Timescale:Ongoing. The World vs MS is an ongoing, ambitious social movement that has united the world in the fight ... As the world’s first pharma-sponsored emoji, it reinforces

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

Azafaros expands executive team with three senior hires

Rounding out the new hires is Louise Kooij, who joins as head of finance and operations from Sanofi-Genzyme. ... Before this, she held the position of head of business operations Europe at Sanofi-Genzyme Europe, after working as vice president, business
New faces at Prime Global, Swordfish Advertising and Wilmington Healthcare

She has worked with global brands including Sanofi Genzyme and Novartis.
Lucid Group announces new hires at its creative and digital agency Bluedog

Lucid Group had a successful run at the Comm uniqué awards this year, bringing home the Excellence in Professional Education Programmes award for its company Vivid’s work for Sanofi
Sobi names Holly May VP of sales and marketing, US

at Sanofi Genzyme. ... Prior to her 17-year career at Sanofi, May held various sales positions at DuPont Pharmaceuticals and Endo.
Sanofi appoints Bill Sibold to lead its Genzyme business

Sanofi has appointed Bill Sibold as executive vice president for Sanofi Genzyme in a move that will also see he join the company's executive committee. ... Previously head of Sanofi Genzyme’s multiple sclerosis, oncology and immunology organisation,

More from appointments
Approximately 1 fully matching, plus 12 partially matching documents found.

Latest from PMHub

Havas Lynx Group

AbbVie. ALK. Astellas. AstraZeneca. Bayer. Boehringer Ingelheim. BI. BMS. Celgene. Sanofi Genzyme. ... Sanofi. Siemens. Teva. UCB. ViiV.
Lucid Group are shortlisted in three categories for Communiqué 2020

for Sanofi Genzyme. Category: The Real Science Award for Medical Affairs Agency of the Year.
Lucid Group make the cut at the PMEAs 2017

OptiMiSe: a Multichannel Learning Platform for Clinical Behaviour Change Among Multiple Sclerosis Specialist Nurses, by Sanofi Genzyme, with support from Lucid Group.
Frontera Group

Could mHealth save healthcare? The rare disease project has really transformed the Sanofi Genzyme rare disease franchise. ... Tom Rigden, Marketing Manager, Rare Disease Portfolio - Sanofi. "I had the pleasure of working with Frontera across a number of